The structure of the RBD-E77 Fab complex reveals neutralization and immune escape of SARS-CoV-2
Description
The spike protein (S) of SARS-CoV-2 is the major target of neutralizing antibodies and vaccines. Antibodies that target the receptor-binding domain (RBD) of S have high potency in preventing viral infection. The ongoing evolution of SARS-CoV-2
